SG Americas Securities LLC increased its holdings in Marsh & McLennan Companies, Inc. (NYSE:MMC - Free Report) by 3,146.7% in the 1st quarter, according to its most recent disclosure with the SEC. The firm owned 113,016 shares of the financial services provider's stock after acquiring an additional 109,535 shares during the period. SG Americas Securities LLC's holdings in Marsh & McLennan Companies were worth $27,579,000 at the end of the most recent quarter.
Several other hedge funds also recently added to or reduced their stakes in the business. Sierra Ocean LLC acquired a new position in Marsh & McLennan Companies during the fourth quarter worth $36,000. Ameriflex Group Inc. acquired a new position in Marsh & McLennan Companies during the fourth quarter worth $37,000. City Holding Co. acquired a new position in Marsh & McLennan Companies during the first quarter worth $37,000. Transce3nd LLC acquired a new position in Marsh & McLennan Companies during the fourth quarter worth $39,000. Finally, Golden State Wealth Management LLC acquired a new position in Marsh & McLennan Companies during the fourth quarter worth $41,000. 87.99% of the stock is currently owned by hedge funds and other institutional investors.
Marsh & McLennan Companies Stock Up 0.9%
NYSE:MMC traded up $1.98 during trading hours on Thursday, hitting $219.27. The company's stock had a trading volume of 2,135,093 shares, compared to its average volume of 1,935,202. The stock has a market capitalization of $108.04 billion, a P/E ratio of 26.77, a price-to-earnings-growth ratio of 2.70 and a beta of 0.83. The stock has a fifty day moving average of $226.47 and a 200-day moving average of $225.50. The company has a current ratio of 1.13, a quick ratio of 1.13 and a debt-to-equity ratio of 1.44. Marsh & McLennan Companies, Inc. has a 52-week low of $207.21 and a 52-week high of $248.00.
Marsh & McLennan Companies (NYSE:MMC - Get Free Report) last issued its quarterly earnings data on Thursday, April 17th. The financial services provider reported $3.06 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.02 by $0.04. The company had revenue of $6.70 billion for the quarter, compared to analyst estimates of $7.08 billion. Marsh & McLennan Companies had a return on equity of 32.60% and a net margin of 16.60%. During the same quarter last year, the company posted $2.89 earnings per share. On average, equities analysts forecast that Marsh & McLennan Companies, Inc. will post 9.61 earnings per share for the current year.
Analyst Ratings Changes
Several brokerages have recently issued reports on MMC. Jefferies Financial Group increased their price objective on Marsh & McLennan Companies from $237.00 to $244.00 and gave the company a "hold" rating in a research note on Friday, April 11th. Barclays increased their price objective on Marsh & McLennan Companies from $246.00 to $249.00 and gave the company an "equal weight" rating in a research note on Friday, April 11th. UBS Group increased their price objective on Marsh & McLennan Companies from $259.00 to $261.00 and gave the company a "buy" rating in a research note on Wednesday, April 9th. Redburn Atlantic began coverage on Marsh & McLennan Companies in a research note on Tuesday, March 25th. They issued a "buy" rating and a $281.00 price objective on the stock. Finally, Keefe, Bruyette & Woods reduced their price objective on Marsh & McLennan Companies from $220.00 to $215.00 and set an "underperform" rating on the stock in a research note on Monday, April 21st. Two investment analysts have rated the stock with a sell rating, seven have assigned a hold rating and five have given a buy rating to the company's stock. According to MarketBeat, the company currently has a consensus rating of "Hold" and an average target price of $241.93.
Check Out Our Latest Analysis on Marsh & McLennan Companies
Insiders Place Their Bets
In related news, SVP Paul Beswick sold 2,237 shares of the firm's stock in a transaction dated Thursday, April 3rd. The stock was sold at an average price of $246.00, for a total transaction of $550,302.00. Following the transaction, the senior vice president now owns 13,522 shares of the company's stock, valued at $3,326,412. This trade represents a 14.20% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, CEO Dean Michael Klisura sold 9,569 shares of the firm's stock in a transaction dated Monday, March 31st. The stock was sold at an average price of $245.00, for a total value of $2,344,405.00. Following the transaction, the chief executive officer now directly owns 20,935 shares in the company, valued at approximately $5,129,075. This represents a 31.37% decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 0.35% of the company's stock.
About Marsh & McLennan Companies
(
Free Report)
Marsh & McLennan Cos., Inc is a professional services firm, which engages in offering clients advice and solutions in risk, strategy, and people. It operates through the Risk and Insurance Services, and Consulting segments. The Risk and Insurance Services segment is involved in risk management activities, as well as insurance and reinsurance broking and services.
Further Reading
Before you consider Marsh & McLennan Companies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Marsh & McLennan Companies wasn't on the list.
While Marsh & McLennan Companies currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.
Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
